ATRS
NASDAQ:ATRS
Antares Pharma, Inc.
- Stock
Last Close
5.58
24/04 19:47
Volume Today
1.76M
Avg: 5.23M
PE Ratio
20.05
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 6.16M - | 5.79M 5.98% | 5.53M 4.60% | 7.30M 32.13% | 10.31M 41.25% | 13.68M 32.61% | 17.11M 25.10% | 14.88M 13.02% | |
average payables | 8.23M - | 7.63M 7.24% | 6.54M 14.33% | 6.92M 5.88% | 8.55M 23.48% | 12.02M 40.65% | 14.55M 21.04% | 16.63M 14.27% | |
average receivables | 2.27M - | 5.73M 152.23% | 8.51M 48.53% | 10.48M 23.06% | 20.65M 97.11% | 36.36M 76.11% | 46.84M 28.80% | 66.68M 42.38% | |
book value per share | 0.32 - | 0.46 44.93% | 0.29 36.21% | 0.21 26.32% | 0.24 11.39% | 0.27 12.28% | 0.72 166.77% | 1.06 47.55% | |
capex per share | -0.04 - | -0.05 5.34% | -0.03 29.18% | -0.01 74.85% | -0.01 32.45% | -0.01 111.22% | -0.09 659.11% | -0.04 54.72% | |
capex to depreciation | -4.62 - | -4.26 7.76% | -2.69 36.83% | -0.60 77.60% | -0.33 45.54% | -0.92 180.03% | -5.56 505.34% | -1.70 69.51% | |
capex to operating cash flow | 0.21 - | 0.24 10.46% | 0.33 38.95% | 0.05 83.34% | 0.05 6.00% | 0.22 328.95% | -0.69 409.64% | -0.18 73.64% | |
capex to revenue | -0.21 - | -0.15 31.34% | -0.10 34.54% | -0.02 75.74% | -0.01 39.52% | -0.02 34.87% | -0.10 414.93% | -0.04 63.19% | |
cash per share | 0.31 - | 0.33 6.58% | 0.18 45.29% | 0.20 13.08% | 0.17 15.31% | 0.23 31.72% | 0.32 41.86% | 0.40 26.39% | |
days of inventory on hand | 190.35 - | 107.38 43.59% | 67.47 37.17% | 123.26 82.68% | 133.36 8.19% | 115.70 13.24% | 105.37 8.93% | 61.71 41.44% | |
days payables outstanding | 327.15 - | 97.31 70.25% | 99.87 2.63% | 79.16 20.74% | 130.83 65.27% | 93.32 28.67% | 93.67 0.38% | 91.17 2.67% | |
days sales outstanding | 48.34 - | 63.57 31.51% | 63.42 0.25% | 79.53 25.41% | 168.95 112.44% | 127.62 24.46% | 122.87 3.72% | 164.68 34.02% | |
debt to assets | 0.40 - | 0.21 48.33% | 0.32 53.60% | 0.55 72.43% | 0.56 1.73% | 0.59 5.60% | 0.44 25.43% | 0.32 27.78% | |
debt to equity | 0.67 - | 0.26 60.96% | 0.47 78.62% | 1.22 160.50% | 1.26 3.91% | 1.44 13.64% | 0.78 45.38% | 0.47 40.69% | |
dividend yield | |||||||||
earnings yield | -0.10 - | -0.12 11.16% | -0.07 42.13% | -0.05 20.00% | -0.01 72.72% | -0.00 85.53% | 0.08 4,086.47% | 0.08 7.95% | |
enterprise value | 301.48M - | 144.48M 52.08% | 333.42M 130.77% | 308.84M 7.37% | 440.25M 42.55% | 971.13M 120.58% | 651.57M 32.91% | 550.90M 15.45% | |
enterprise value over ebitda | -8.89 - | -7.64 14.10% | -14.90 95.05% | -23.37 56.85% | -394.49 1,588.11% | 238.08 160.35% | 39.89 83.25% | 8.33 79.13% | |
ev to operating cash flow | -11.45 - | -5.12 55.25% | -21.94 328.26% | -13.37 39.05% | -25.42 90.05% | -91.49 259.96% | 30.56 133.41% | 15.04 50.77% | |
ev to sales | 11.38 - | 3.16 72.18% | 6.38 101.76% | 5.67 11.27% | 6.93 22.28% | 7.84 13.18% | 4.36 44.45% | 2.99 31.25% | |
free cash flow per share | -0.25 - | -0.24 2.87% | -0.13 45.23% | -0.16 19.77% | -0.11 28.36% | -0.06 42.81% | 0.04 163.12% | 0.18 347.46% | |
free cash flow yield | -0.10 - | -0.20 106.29% | -0.06 71.56% | -0.08 40.24% | -0.04 47.59% | -0.01 66.90% | 0.01 174.36% | 0.05 400.10% | |
graham net net | 0.14 - | 0.27 93.85% | 0.10 61.23% | 0.03 73.37% | 0.04 41.26% | 0.04 0.55% | 0.04 1.31% | 0.32 709.71% | |
graham number | 1.38 - | 1.20 12.91% | 1.02 15.69% | 0.72 29.05% | 0.46 35.56% | 0.25 47.02% | 2.34 850.17% | 2.58 10.24% | |
income quality | 0.75 - | 1.36 82.21% | 0.62 54.26% | 1.38 120.94% | 2.66 92.76% | 5.24 96.96% | 0.38 92.76% | 0.79 108.54% | |
intangibles to total assets | 0.06 - | 0.04 27.88% | 0.05 13.41% | 0.03 29.08% | 0.02 35.02% | 0.01 45.69% | 0.04 248.96% | 0.07 78.20% | |
interest coverage | -11.56 - | -1.53 86.74% | 0.28 118.23% | 3.60 1,186.60% | |||||
interest debt per share | 0.17 - | 0.17 1.35% | 0.22 30.62% | 0.28 23.94% | 0.14 47.80% | ||||
inventory turnover | 1.92 - | 3.40 77.26% | 5.41 59.15% | 2.96 45.26% | 2.74 7.57% | 3.15 15.26% | 3.46 9.80% | 5.91 70.75% | |
invested capital | 0.74 - | 0.64 13.06% | 0.76 18.61% | 0.35 53.74% | 0.14 61.44% | ||||
market cap | 335.51M - | 177.38M 47.13% | 361.13M 103.59% | 310.55M 14.01% | 443.02M 42.66% | 952.69M 115.04% | 662.60M 30.45% | 592.86M 10.53% | |
net current asset value | 26.06M - | 48.54M 86.26% | 24.16M 50.23% | 14.74M 38.96% | 22.03M 49.42% | 30.20M 37.05% | 33.17M 9.87% | 79.96M 141.03% | |
net debt to ebitda | 1.00 - | 1.74 73.29% | 1.24 28.80% | 0.13 89.59% | 2.48 1,822.29% | 4.52 82.43% | -0.68 114.94% | -0.63 6.13% | |
net income per share | -0.27 - | -0.14 47.66% | -0.16 11.43% | -0.11 31.68% | -0.04 62.72% | -0.01 75% | 0.34 3,484.26% | 0.28 17.64% | |
operating cash flow per share | -0.20 - | -0.19 4.64% | -0.10 49.03% | -0.15 50.95% | -0.11 28.13% | -0.05 50.76% | 0.13 345.15% | 0.22 71.76% | |
payables turnover | 1.12 - | 3.75 236.18% | 3.65 2.56% | 4.61 26.16% | 2.79 39.49% | 3.91 40.20% | 3.90 0.38% | 4.00 2.74% | |
receivables turnover | 7.55 - | 5.74 23.96% | 5.76 0.25% | 4.59 20.26% | 2.16 52.93% | 2.86 32.38% | 2.97 3.86% | 2.22 25.39% | |
research and ddevelopement to revenue | 0.70 - | 0.43 38.55% | 0.40 6.39% | 0.24 40.39% | 0.19 19.57% | 0.09 55.78% | 0.07 21.12% | 0.08 16.51% | |
return on tangible assets | -0.54 - | -0.25 53.01% | -0.39 51.09% | -0.23 39.50% | -0.08 67.63% | -0.02 79.52% | 0.28 1,885.12% | 0.19 29.65% | |
revenue per share | 0.20 - | 0.31 53.43% | 0.34 8.18% | 0.35 3.68% | 0.39 11.70% | 0.61 56.60% | 0.90 47.42% | 1.11 22.98% | |
roe | -0.85 - | -0.31 63.89% | -0.54 74.67% | -0.50 7.28% | -0.17 66.53% | -0.04 77.74% | 0.47 1,368.59% | 0.26 44.18% | |
roic | 3.76 - | -1.52 140.47% | -8.04 429.07% | -1.08 86.59% | -0.19 82.19% | 0.01 107.03% | 0.86 6,242.08% | 0.45 47.33% | |
sales general and administrative to revenue | 1.20 - | 0.59 50.75% | 0.51 14.31% | 0.56 10.16% | 0.58 3.89% | 0.50 13.78% | 0.42 15.88% | ||
shareholders equity per share | 0.32 - | 0.46 44.93% | 0.29 36.21% | 0.21 26.32% | 0.24 11.39% | 0.27 12.28% | 0.72 166.77% | 1.06 47.55% | |
stock based compensation to revenue | 0.10 - | 0.08 19.09% | 0.05 39.79% | 0.06 32.68% | 0.08 21.10% | 0.05 32.62% | 0.05 1.71% | 0.04 18.00% | |
tangible asset value | 37.22M - | 63.51M 70.66% | 42.08M 33.75% | 31.05M 26.21% | 37.08M 19.40% | 52.93M 42.76% | 110.33M 108.45% | 156.78M 42.11% | |
tangible book value per share | 0.29 - | 0.43 51.98% | 0.27 37.34% | 0.20 26.71% | 0.23 14.40% | 0.26 14.71% | 0.66 154.44% | 0.94 42.11% | |
working capital | 29.41M - | 49.24M 67.43% | 25.36M 48.50% | 39.80M 56.97% | 44.12M 10.83% | 76.03M 72.35% | 63.39M 16.63% | 102.78M 62.15% |
All numbers in USD (except ratios and percentages)